Fatebenefratelli Hospital Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2007
NCT00637975
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Fatebenefratelli and Ophtalmic Hospital | Fatebenefratelli San Giovanni Calibita - Tiberine Island

Active Ingredients

Drugs in Phase 4 Trials (2)

clonidine (catapres) (1 trial)

sufentanil (1 trial)

Drugs in Phase 3 Trials (2)

docetaxel (taxotere) (1 trial)

erlotinib (tarceva) (1 trial)

Drugs in Phase 2 Trials (2)

oxycodone (oxycontin) (1 trial)

pregabalin (lyrica) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Non-Small-Cell Lung (Phase 3)

Labor Pain (Phase 4)

Lung Neoplasms (Phase 3)

Neuralgia (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 6